Onboard sampling of the rockfish and lingcod commerical passenger fishing vessel industry in northern and central California, 1992

In 1992 fishery technicians sampled 230 commercial passenger fishing vessel (CPFV) trips targeting rockfish and lingcod from the port areas of Fort Bragg, Bodega Bay, San Francisco, Monterey, and Morro Bay. The skippers of 44 vessels, and 2,190 anglers, cooperated in the study. Species composition by port area and month, catch-per-unit-effort, mean length, and length frequency of lingcod and the 18 most frequently observed rockfish species are presented, as well as fishing effort relative to time, depth, and distance from port. Total catch estimates based on unadjusted and adjusted logbook records are summarized. Average catch of kept fish per angler day was 12.6 and average catch of kept fish per angler hour was 4.0. A continuing trend of an increasing frequency of trips to deep (> 40 fm) locations was observed in the Bodega Bay, San Francisco, and Monterey areas. Bodega Bay and San Francisco showed the highest frequency of trips to distant locations. Sixty species comprised of 29,731 fish were observed caught during the study. Rockfish comprised 93.5% by number of the total observed catch. The five most frequently observed species were blue, yellowtail, widow and rosy rockfishes, and bocaccio, with lingcod ranking eighth. CPFV angler success, as determined by catch per angler hour, generally increased in all ports in 1992 compared to previous 1988-91 data (Reilly et al. 1993). However, port-specific areas of major concern were identified for chilipepper, lingcod, and black rockfish, and to a lesser extent brown, canary, vermilion, yelloweye, widow and greenspotted rockfishes. These areas of concern included steadily declining catch rate, steadily declining mean length, and/or a high percentage of sexually immature fish in the sampled catch. Recent sampling of the commercial hook-and-line fishery in northern and central California indicates that most rockfishes taken by CPFV anglers are also harvested commercially. (105pp.

Comparing, contrasting, and integrating dissemination and implementation outcomes included in the RE-AIM and Implementation Outcomes Frameworks

As the field of dissemination and implementation science matures, there are a myriad of outcomes, identified in numerous frameworks, that can be considered across individual, organizational, and population levels. This can lead to difficulty in summarizing literature, comparing across studies, and advancing translational science. This manuscript sought to (1) compare, contrast, and integrate the outcomes included in the RE-AIM and Implementation Outcomes Frameworks (IOF) and (2) expand RE-AIM indicators to include relevant IOF dissemination and implementation outcomes. Cross tabular comparisons were made between the constitutive definitions of each construct, across frameworks, to reconcile apparent discrepancies between approaches and to distinguish between implementation outcomes and implementation antecedents. A great deal of consistency was identified across approaches, including adoption (the intention, initial decision, or action to employ an evidence-based intervention), fidelity/implementation (the degree to which an intervention was delivered as intended), organizational maintenance/sustainability (extent to which a newly implemented treatment is maintained or institutionalized), and cost. The IOF construct of penetration was defined as a higher-order construct that may encompass the reach, adoption, and organizational maintenance outcomes within RE-AIM. Within the IOF approach acceptability, appropriateness, and feasibility did not match constitutive definitions of dissemination or implementation but rather reflected theoretical antecedents of implementation outcomes. Integration of the IOF approach across RE-AIM indicators was successfully achieved by expanding the operational definitions of RE-AIM to include antecedents to reach, adoption, implementation, and organizational maintenance. Additional combined metrics were also introduced including penetration, individual level utility, service provider utility, organizational utility, and systemic utility. The expanded RE-AIM indicators move beyond the current approaches described within both the REAIM framework and IOF and provides additional planning and evaluation targets that can contribute to the scientific field and increase the translation of evidence into practice

Managerial challenges of publicly funded principal investigators

Principal investigators (PI) are at the nexus of university business collaborations through their leadership of funded research grants. In fulfilling their multiple roles, PIs are involved in a range of different activities, from direct scientific supervision of junior scientists, the organisation of new scientific avenues to engaging with industrial partners. With the increased impetus for public research to produce wealth through science commercialisation, research is increasingly orchestrated through programmes which seek to connect research avenues and markets. The role of PIs is of growing importance. The extent of managerial challenges encountered by scientists in the context of their PI role has not been the focus of any empirical studies. This paper examines the managerial challenges experienced by publicly funded PIs. Our study, set in the context of the Irish research system, found three foci of PI managerial challenges – project management, project adaptability and project network management

The role of the automation development group in analytical research and development at Dupont Merck

Laboratory robotics has been firmly established in many non-QC laboratories as a valuable tool for automating pharmaceutical dosage form analysis. Often a single project or product line is used to justify an initial robot purchase thus introducing robotics to the laboratory for the first time. However, to gain widespread acceptance within the laboratory and to justify further investment in robotics, existing robots must be used to develop analyses for existing manual methods as well as new projects beyond the scope off the original purchase justification. The Automation Development Group in Analytical Research and Development is a team of analysts primarily devoted to developing new methods and adapting existing methods for the robot. This team approach developed the expertise and synergy necessary to significantly expand the contribution of robotics to automation in the authors' laboratory

Prompt Problems: A New Programming Exercise for the Generative AI Era

Large Language Models (LLMs) are revolutionizing the field of computing education with their powerful code-generating capabilities. Traditional pedagogical practices have focused on code writing tasks, but there is now a shift in importance towards code reading, comprehension and evaluation of LLM-generated code. Alongside this shift, an important new skill is emerging -- the ability to solve programming tasks by constructing good prompts for code-generating models. In this work we introduce a new type of programming exercise to hone this nascent skill: 'Prompt Problems'. Prompt Problems are designed to help students learn how to write effective prompts for AI code generators. A student solves a Prompt Problem by crafting a natural language prompt which, when provided as input to an LLM, outputs code that successfully solves a specified programming task. We also present a new web-based tool called Promptly which hosts a repository of Prompt Problems and supports the automated evaluation of prompt-generated code. We deploy Promptly for the first time in one CS1 and one CS2 course and describe our experiences, which include student perceptions of this new type of activity and their interactions with the tool. We find that students are enthusiastic about Prompt Problems, and appreciate how the problems engage their computational thinking skills and expose them to new programming constructs. We discuss ideas for the future development of new variations of Prompt Problems, and the need to carefully study their integration into classroom practice.Comment: Accepted to SIGCSE'24. arXiv admin note: substantial text overlap with arXiv:2307.1636

Motor vehicle accidents in patients with an implantable cardioverter-defibrillator

Objectives.This study was designed to examine driving safety in patients at risk for sudden death after implantation of a cardioverter-defibrillator.Background.Cardioverter-defibrillators are frequently implanted in patients at high risk for sudden death. Despite concern about the safety of driving in these patients, little is known about their actual motor vehicle accident rates.Methods.Surveys were sent to all 742 physicians in the United States involved in cardioverter-defibrillator implantation and follow-up. Physicians were questioned about numbers of patients followed up, numbers of fatal and nonfatal accidents, physician recommendations to patients about driving and knowledge of state driving laws.Results.Surveys were returned by 452 physicians (61%). A total of 30 motor vehicle accidents related to shocks from implantable defibrillators were reported by 25 physicians over a 12-year period from 1980 to 1992. Of these, nine were fatal accidents involving eight patients with a defibrillator and one passenger in a car driven by a patient. No bystanders were fatally injured. There were 21 nonfatal accidents involving 15 patients, 3 passengers and 3 bystanders. The estimated fatality rate for patients with a defibrillator, 7.5/100,000 patient-years, is significantly lower than that for the general population (18.4/100,000 patient-years, p < 0.05). The estimated injury rate, 17.6/100,000 patient-years, is also significantly lower than that for the general public (2,224/100,000 patient-years, p < 0.05). Only 10.5% (30 of 286) of all defibrillator discharges during driving resulted in accidents. Regarding physician recommendations, most physicians (58.1%) ask their patients to wait a mean (± SD) of 7.3 ± 3.4 months after implantation or a shock before driving again.Conclusions.The motor vehicle accident rate caused by discharge from an implantable cardioverter-defibrillator is low. Although restricting driving for a short period of time after implantation may be appropriate, excessive restrictions or a total ban on driving appears to be unwarranted

Glycolaldehyde formation via the dimerization of the formyl radical

Glycolaldehyde, the simplest monosaccharide sugar, has recently been detected in low- and high-mass star-forming cores. Following our previous investigation into glycolaldehyde formation, we now consider a further mechanism for the formation of glycolaldehyde that involves the dimerization of the formyl radical, HCO. Quantum mechanical investigation of the HCO dimerization process upon an ice surface is predicted to be barrierless and therefore fast. In an astrophysical context, we show that this mechanism can be very efficient in star-forming cores. It is limited by the availability of the formyl radical, but models suggest that only very small amounts of CO are required to be converted to HCO to meet the observational constraints

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.

BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be able to reverse the anticoagulant effect of dabigatran in patients who had uncontrolled bleeding (group A) or were about to undergo an urgent procedure (group B). The primary end point was the maximum percentage reversal of the anticoagulant effect of dabigatran within 4 hours after the administration of idarucizumab, on the basis of the diluted thrombin time or ecarin clotting time. Secondary end points included the restoration of hemostasis and safety measures. RESULTS: A total of 503 patients were enrolled: 301 in group A, and 202 in group B. The median maximum percentage reversal of dabigatran was 100% (95% confidence interval, 100 to 100), on the basis of either the diluted thrombin time or the ecarin clotting time. In group A, 137 patients (45.5%) presented with gastrointestinal bleeding and 98 (32.6%) presented with intracranial hemorrhage; among the patients who could be assessed, the median time to the cessation of bleeding was 2.5 hours. In group B, the median time to the initiation of the intended procedure was 1.6 hours; periprocedural hemostasis was assessed as normal in 93.4% of the patients, mildly abnormal in 5.1%, and moderately abnormal in 1.5%. At 90 days, thrombotic events had occurred in 6.3% of the patients in group A and in 7.4% in group B, and the mortality rate was 18.8% and 18.9%, respectively. There were no serious adverse safety signals. CONCLUSIONS: In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947 .)